Chindex International Announces Shelf Registration, Related Strategy an...( BETHESDA Md. May 13 /Xinhua-- Chi...)

BETHESDA, Md., May 13 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX), a leading independent American provider of Western healthcare services and products in the People's Republic of China, announced that it has filed a shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, would allow the Company to sell, from time to time, up to $100 million of its common stock or related securities in one or more offerings. While the Company does not have any present intention to use the shelf registration statement, it is intended to give Chindex greater flexibility to take advantage of favorable market conditions and to respond to strategic opportunities as they may arise. The Company is not required to offer or sell any securities under the shelf registration statement and will consider, to the extent practicable, offerings that would not be dilutive to stockholders. The terms of any offering under the shelf registration statement will be established at the time of the offering.

In connection with the filing, Roberta Lipson, the Company's Chief Executive Officer, elaborated on the related strategy: "Here in China, the healthcare industry continues to grow rapidly in many different ways. We recently completed financings with J.P. Morgan, the International Finance Corporation and DEG - Deutsche Investitions toward two new hospital facilities. These projects, which are moving forward and whose progress will be updated periodically, will support the Company's growth and represent the kind of expansion opportunities that we believe will allow us to exploit the rapid growth of the healthcare business in China.

"In addition, from time to time numerous other oppo
'/>"/>